BMJ  2004;329:460-461 (21 August), doi:10.1136/bmj.329.7463.460-c

Letter

Open letter to Annette King, Minister of Health, New Zealand

Official response is misleading

The first 150 words of the full text of this article appear below.

EDITOR—Matheson says that it is misleading for Herxheimer in his open letter to New Zealand's health minister to report that Medsafe, the New Zealand medicines regulator, intended to stop funding the intensive medicines monitoring programme (previous letter).1 2 Notice was given to the University of Otago on 4 March 2004 that funding would be withdrawn as of 30 June. Medsafe's intention was demonstrated further by the withdrawal of all usual references to the programme from the latest issue of their publication Prescriber Update, and from their web site. It is Matheson's letter that is misleading.

Matheson is also critical of the fact that the collection of data comes from multiple sources and is largely paper-based. He overlooks the fact that the programme has no operational alternative because of failure of Medsafe or the ministry to have prescriptions for monitored medicines recorded by a central agency. This is in . . . [Full text of this article]

David Coulter, retired

264 Highgate, Roslyn, Dunedin 9001, New Zealand dmcoulter@xtra.co.nz


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Open letter to Annette King, Minister of Health, New Zealand
Andrew Herxheimer
BMJ 2004 329: 51. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ